ADALIMUMAB SERUM DRUG LEVELS AND ANTI-DRUG ANTIBODIES: ASSOCIATION TO DISEASE ACTIVITY AND DRUG SURVIVAL IN INFLAMMATORY ARTHRITIS PATIENTS

被引：0
|
作者：
Jyssum, I. [1 ,2 ]
Gehin, J. E. [3 ]
Kristianslund, E. [1 ]
Sexton, J. [1 ]
Worren, D. [3 ]
Hu, Y. [4 ]
Kvien, T. K. [1 ]
Haavardsholm, E. A. [1 ,2 ]
Bolstad, N. [3 ]
Syversen, S. W. [1 ]
Goll, G. L. [1 ]
机构：
[1] Diakonhjemmet Hosp, Ctr treatment Rheumat & Musculoskeletal Dis REMED, Oslo, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
[3] Norwegian Radium Hosp, Dept Med Biochem, Oslo, Norway
[4] Lillehammer Hosp, Dept Rheumatol, Lillehammer, Norway
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Inflammatory arthritides; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.1369
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0345
引用
收藏
页码：421 / 422
页数：2
相关论文
共 50 条
  • [31] Therapeutic Drug Monitoring of the Biosimilar (AMJEVITA™, Adalimumab-atto) Using Labcorp Adalimumab Assay for Drug Level and Anti-Drug Antibodies
    Chun, Kelly Y.
    Bastidas, Monique
    Yeo, Lythou
    Magpantay, Susie
    Scott, Judah
    Zikry, Michael
    Galdamez, Wayne
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S5 - S6
  • [32] Preventing Crohn's Disease recurrence after resection with adalimumab: Role of drug and anti-drug antibody levels
    Wright, E.
    Kamm, M.
    Selvaraj, F.
    Princen, F.
    De Cruz, P.
    Hamilton, A.
    Ritchie, K.
    Krejany, E.
    Gorelik, A.
    Liew, D.
    Prideaux, L.
    Lawrance, I.
    Andrews, J.
    Bampton, P.
    Jakobovits, S.
    Florin, T.
    Gibson, P.
    Debinski, H.
    Gearry, R.
    Macrae, F.
    Samuel, D.
    Kronborg, I.
    Radford-Smith, G.
    Selby, W.
    Johnston, M.
    Woods, R.
    Elliott, P. R.
    Bell, S.
    Brown, S.
    Connell, W.
    Desmond, P.
    Singh, S.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S373 - S373
  • [33] Preventing Crohn's Disease Recurrence After Resection With Adalimumab: Role of Drug and Anti-Drug Antibody Levels
    Wright, Emily K.
    Kamm, Michael A.
    Selvaraj, Fabiyola
    Princen, Fred
    De Cruz, Peter
    Hamilton, Amy L.
    Ritchie, Kathryn
    Krejany, Efrosinia O.
    Gorelik, Alexandra
    Liew, Danny
    Prideaux, Lani
    Lawrance, Ian C.
    Andrews, Jane M.
    Bampton, Peter A.
    Jakobovits, Simon
    Florin, Tim
    Gibson, Peter R.
    Debinski, Henry
    Gearry, Richard B.
    Macrae, Finlay A.
    Samuel, Douglas
    Kronborg, Ian
    Radford-Smith, Graham L.
    Selby, Warwick
    Johnston, Michael J.
    Woods, Rodney
    Elliott, Peter R.
    Bell, Sally
    Brown, Steven J.
    Connell, William
    Desmond, Paul V.
    Singh, Sharat
    GASTROENTEROLOGY, 2015, 148 (04) : S849 - S849
  • [34] Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays
    Barclay, Murray L.
    Karim, Shwan
    Helms, Esther T. Johanna
    Keating, Paula E.
    Hock, Barry
    Stamp, Lisa K.
    Schultz, Michael
    INTERNAL MEDICINE JOURNAL, 2019, 49 (04) : 513 - 518
  • [35] Anti-drug Antibodies Formation During Tapering and Stopping of Methotrexate in Rheumatoid Arthritis Patients with Longstanding Use of Adalimumab
    Layegh, Zohra
    de Jong, Pascal
    Atiqi, Sadaf
    Loeff, Floris
    Dijk, Lisanne
    Vaz, Gaelle
    Dolhain, Radboud J. E. M.
    Rispens, Theo
    Wolbink, Gertjan
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2121 - 2122
  • [36] Risk factors for the development of anti-drug antibodies to infliximab and adalimumab in Crohn's disease
    Khoo, E.
    Lord, A.
    Hanigan, K.
    Croft, A.
    Radford-Smith, G.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S378 - S379
  • [37] Association between TNFi anti-drug antibodies, smoking, and disease activity in patients with inflammatory arthritis: Results from a Norwegian cross-sectional observational study
    Michelsen, Brigitte
    Berget, Kristine Thomassen
    Kavanaugh, Arthur
    Haugeberg, Glenn
    RHEUMATOLOGY AND THERAPY, 2022, 9 (04) : 1171 - 1179
  • [38] Association between TNFi anti-drug antibodies, smoking, and disease activity in patients with inflammatory arthritis: Results from a Norwegian cross-sectional observational study
    Brigitte Michelsen
    Kristine Thomassen Berget
    Arthur Kavanaugh
    Glenn Haugeberg
    Rheumatology and Therapy, 2022, 9 : 1171 - 1179
  • [39] The association between drug levels, anti-drug antibodies, and therapeutic response during infliximab therapy in pediatric Crohn's disease
    Stein, R. E.
    Lee, D. Y.
    Leonard, M. B.
    Thayu, M.
    Herskovitz, R. M.
    Kerbowski, T.
    Baldassano, R. N.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S434 - S434
  • [40] Stability of anti-drug antibodies in human serum samples
    Solberg, Helene
    Bartholdy, Christina
    Landsy, Lone Hummelshoj
    Andresen, Lars Ole
    JOURNAL OF IMMUNOLOGICAL METHODS, 2024, 525
12345